Glass House Brands Inc Dossier
|
SectorConsumer Staples IndustryPersonal Care Products Beta (adjusted)0.77 Intrinsic Value $7.84median of 2 methodsbased on filings through 31 Dec 2025 Market Price $5.32Price as of 1 Oct 2026 UndervaluedIntrinsic value is 47% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $501.4M Enterprise Value $546.7M Shares Outstanding 81.9M diluted Next Earnings Date18 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Glass House Brands Inc. operates the largest greenhouse cannabis cultivation footprint in California, positioning it as a potential long-term low-cost leader. However, the company is currently navigating a challenging operational phase characterized by compressed gross margins, elevated production costs due to labor inefficiencies, and significant cash burn. While its recent corporate restructuring to segregate adult-use retail from medical operations represents a bold bid to uplist to the NYSE and capitalize on federal rescheduling, near-term profitability remains highly sensitive to volatile wholesale biomass pricing in California. Until the company demonstrates a sustainable path to its $95/lb cost target and positive free cash flow, a Hold recommendation is warranted. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$15.00 Mean target$16.00 High · most bullish analyst$17.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario Persistent oversupply in the California market keeps wholesale biomass prices depressed below $170/lb. Labor inefficiencies and expansion friction prevent the company from achieving its cost-reduction targets, leading to continued negative Adjusted EBITDA and further dilutive equity raises under its $50 million ATM program. The NYSE uplisting is delayed or blocked. Base CaseCentral scenario The company successfully executes its H2 2026 cost-reduction initiatives, bringing production costs down toward the $95/lb target as Greenhouse 2 and Greenhouse 4 scale. Wholesale biomass prices in California stabilize in the mid-$180s range. The medical-only corporate structure satisfies NYSE listing requirements, leading to successful uplisting and improved institutional capital access. Bull CaseUpside scenario Glass House Brands is a highly compelling play on regulatory arbitrage and scale in the US cannabis market. As the largest producer in California with 5.5 million square feet of greenhouse cultivation capacity (currently operating at only ~50% utilization), the company is uniquely positioned to scale production to 1 million pounds of biomass in 2026. Its industry-leading low-cost structure (~$100-$130/lb) provides a massive competitive advantage. The primary catalyst is the federal rescheduling of medical cannabis to Schedule III, which eliminates the 280E tax burden, facilitates uplisting to major exchanges like the NYSE, and opens the door for massive upside from interstate commerce and international exports. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |